We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Axcelis Technologies (ACLS) Could Be Positioned for a Surge
Read MoreHide Full Article
Axcelis Technologies, Inc. (ACLS - Free Report) is a leading producer of ion implantation equipment that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ACLS’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Axcelis Technologies could be a solid choice for investors.
Current Quarter Estimates for ACLS
In the past 30 days, 2 estimates have gone higher for Axcelis Technologies while none has gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 28 cents a share 30 days ago, to 31 cents today, a move of 10.7%.
Current Year Estimates for ACLS
Meanwhile, Axcelis Technologies’ current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $1.01 per share 30 days ago to $1.09 per share today, an increase of 7.9%.
The stock has also started to move higher lately, adding 18.84% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Axcelis Technologies (ACLS) Could Be Positioned for a Surge
Axcelis Technologies, Inc. (ACLS - Free Report) is a leading producer of ion implantation equipment that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ACLS’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Axcelis Technologies could be a solid choice for investors.
Current Quarter Estimates for ACLS
In the past 30 days, 2 estimates have gone higher for Axcelis Technologies while none has gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 28 cents a share 30 days ago, to 31 cents today, a move of 10.7%.
Current Year Estimates for ACLS
Meanwhile, Axcelis Technologies’ current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $1.01 per share 30 days ago to $1.09 per share today, an increase of 7.9%.
Axcelis Technologies, Inc. Price and Consensus
Axcelis Technologies, Inc. Price and Consensus | Axcelis Technologies, Inc. Quote
Bottom Line
The stock has also started to move higher lately, adding 18.84% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>